See More Hear More Watch More Hear More Get on iTunes
StrictlyVC StrictlyVC

Syros Gets $53M In Series B Funds

Syros Pharmaceuticals, a 1.5-year-old, Watertown, Ma.-based company looking to develop gene control therapies in cancer and other diseases, has raised $53 million in Series B funding led by a large, Boston-based public investment firm, with participation from Polaris Partners, Aisling Capital, and Redmile Group.


More from